Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kiniksa Pharmaceuticals International Plc (NQ: KNSA ) 26.21 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Kiniksa Pharmaceuticals International Plc < Previous 1 2 3 Next > Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 23, 2024 Via Benzinga KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 July 23, 2024 KNSA stock results show that Kiniksa Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday July 23, 2024 Via Benzinga Earnings Outlook For Kiniksa Pharmaceuticals February 27, 2024 Via Benzinga Sector Spotlight: Orphan Drug Developers With Significant Upside June 03, 2024 Via AB Newswire Topics ETFs Exposures Product Safety Sector Spotlight: Orphan Drug Developers With Significant Upside June 03, 2024 The biotech sector is finally beginning to recover following a two year stretch of underperformance that was largely driven by rising interest rates and other macro factors. Biotech has a track record... Via TheNewswire.com Topics ETFs Exposures Product Safety KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 April 23, 2024 KNSA stock results show that Kiniksa Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace The 3 Most Undervalued Biotech Stocks to Buy in December December 15, 2023 Biotech is an increasing area of interest in the financial markets, line your portfolio up with these winning biotech stocks. Via InvestorPlace 7 Underappreciated Biotech Stocks to Pick Up on the Cheap November 09, 2023 With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor. Via InvestorPlace Topics Economy Exposures Economy Earnings Outlook For Kiniksa Pharmaceuticals October 30, 2023 Via Benzinga Why Shares of Kiniksa Pharmaceuticals Jumped Tuesday July 25, 2023 The company reported a big jump in revenue and updated guidance. Via The Motley Fool Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) Near the Top of Equities by Percentage Gain on 7/25 July 25, 2023 Via Investor Brand Network Earnings Scheduled For April 23, 2024 April 23, 2024 Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion. Via Benzinga Earnings Outlook For Kiniksa Pharmaceuticals July 24, 2023 Via Benzinga Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Shares of Longboard Pharmaceuticals, Inc. Via Benzinga Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark September 28, 2023 Amicus Therapeutics sees its Relative Strength Rating move into the 80-plus level. Via Investor's Business Daily 5 Value Stocks In The Healthcare Sector September 11, 2023 Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector August 21, 2023 Via Benzinga Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+ August 16, 2023 Vertex Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81. Via Investor's Business Daily ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold August 15, 2023 One key metric to look for in a stock is an 80-plus Relative Strength Rating. ACELYRIN stock hit that mark on Tuesday, with a jump to 81. Via Investor's Business Daily Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade August 15, 2023 A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance. Via Investor's Business Daily Exelixis Stock Sees Rising Relative Strength Rating August 14, 2023 On Monday, Exelixis stock hit an key technical milestone, with its Relative Strength Rating rising to 87, an increase from 79 the day before. Via Investor's Business Daily Dynavax Technologies Stock Sees Renewed Technical Strength August 07, 2023 Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84. Via Investor's Business Daily Crude Oil Up 1%; Verizon Earnings Beat Views July 25, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05.... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 25, 2023 Via Benzinga Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 25, 2023 Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. Via Benzinga Xerox, Logitech International, Packaging Corporation of America And Other Big Stocks Moving Higher On Tuesday July 25, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Tuesday. Here are some big stocks recording gains in today’s session. Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)... Via Benzinga 5 Value Stocks In The Healthcare Sector July 24, 2023 Via Benzinga 3 Small-Cap Stocks That Are Worth the Gamble July 04, 2023 Although these small-cap stock picks may not be household names, they command significant upside potential for daring speculators. Via InvestorPlace Abcam Stock Earns Relative Strength Rating Upgrade June 20, 2023 A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance. Via Investor's Business Daily < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.